Frequently Asked Questions
LIVER CONDITIONS & WOBENZYM®
How is Wobenzym® used in the treatment
of autoimmune hepatitis?
Wobenzym® has demonstrable efficacy in the
treatment of chronic autoimmune
hepatitis (CAH) and active liver cirrhosis (LC) with a
significant autoimmune process. This is in large part due to the
ability of Wobenzym® to decrease the pathological effect of
circulating immune complexes through its ability to remove immune
complexes fixed in tissues, prevent formation of new immune
complexes in tissues, help to decompose CIC, and lessen the number
of CIC bound to tissues through complement system
Other mechanisms include increases cytotoxic activity of macrophages
and induction of phagocytosis. Researchers concluded that that
Wobenzym appears to be an effective preparation in the treatment of
patients suffering from chronic autoimmune
hepatitis and
active LC.
How
does Wobenzym® help with liver damage due to toxins?
In toxic
hepatitis, Wobenzym has a normalizing affect on liver
enzymes.
What
has been the result of using Wobenzym® with hepatitis B?
Wobenzym® produced a noticeable positive
effect on immune and metabolic disorders caused by
hepatitis B, with a faster tendency to recover,
normalization of spleen and liver size, restoring of liver
functional activity accompanied by a decrease of hyperbilirubinemia
and transaminase activity were found in the test group.
What
has been the result of using Wobenzym® with hepatitis C?
In
hepatitis C, the best results were found with Wobenzym® PS
(Phlogenzym®) which was even superior to ribavirin and a-interferon.
Back
to Frequently Asked Questions